Altmetric

Combination therapy and the start of a new epoch for idiopathic pulmonary fibrosis?

File Description SizeFormat 
AJRCCM Combined Trial Editorial.docxAccepted version44.76 kBMicrosoft WordView/Open
Title: Combination therapy and the start of a new epoch for idiopathic pulmonary fibrosis?
Authors: Maher, TM
Item Type: Journal Article
Issue Date: 6-Oct-2017
Date of Acceptance: 2-Oct-2017
URI: http://hdl.handle.net/10044/1/55782
DOI: https://dx.doi.org/10.1164/rccm.201709-1939ED
ISSN: 1073-449X
Publisher: American Thoracic Society
Start Page: 283
End Page: 284
Journal / Book Title: American Journal of Respiratory and Critical Care Medicine
Volume: 197
Issue: 3
Copyright Statement: © 2017 American Thoracic Society,
Keywords: Science & Technology
Life Sciences & Biomedicine
Critical Care Medicine
Respiratory System
General & Internal Medicine
PIRFENIDONE
SAFETY
ACETYLCYSTEINE
NINTEDANIB
TRIAL
clinical trial
interstitial lung disease
personalised medicine
usual interstitial pneumonia
11 Medical And Health Sciences
Publication Status: Published
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx